Axonal-demyelinating polyneuropathy after subcutaneous foslevodopa/foscarbidopa infusion – case report.
Objective: The aim of this report was to present a patient with Parkinson’s disease (PD) treated with continuous subcutaneous foslevodopa/foscarbidopa infusion (CSFLI) who developed axonal-demyelinating…Baicalein Attenuates Rotenone-Induced Neurodegeneration by Regulating BDNF/CREB/Akt Signaling in Parkinson’s Disease
Objective: To evaluate the therapeutic potential of baicalein and to investigate its underlying neuroprotective mechanism in a rotenone-induced mouse model of Parkinson’s disease. Background: Parkinson’s…Effect of a Live-streaming Tele-exercise in Parkinson’s Disease: a Multicenter, Controlled Trial in South Korea
Objective: To evaluate the effectiveness and safety of a supervised live-streaming home-based tele-exercise program in patients with Parkinson’s disease (PD). Background: Exercise is an important…Rates Of Phenoconvertion And Progression To Functionally Meaningful Impairment In NSD Stage 2B Participants: PPMI cohort
Objective: Describe rates of phenoconversion and progression to functionally meaningful impairment in early Neuronal α-Synuclein Disease (NSD). Background: There is increasing focus on testing disease…TRACK-PD: Understanding Treatment Routines and Adherence in Care – Knowledge and Perspective of People Living with Parkinson’s Disease
Objective: TRACK-PD aimed to assess adherence behaviors and drivers of treatment interruption/discontinuation from the patient perspective. Background: Treatment adherence is critical in Parkinson’s disease (PD),…Integrating Psychology into a Parkinson’s Disease Service – Evaluating Need
Objective: This service evaluation aimed to assess the need for integrated psychological support within a Parkinson’s disease (PD) service by examining referral rates, presenting psychological…The Unholy Marriage Between Ogilvie Syndrome and Parkinson’s Disease
Objective: To demonstrate the dynamic interplay between advanced Parkinson’s disease (PD)–related colonic dysmotility and acute colonic pseudo-obstruction (ACPO; Ogilvie syndrome) and to highlight practical red…NIH Multicenter Consortium for Gut-Brain Communication in Parkinson’s Disease: The Master Protocol and Timeline
Objective: To describe the master protocol and timeline for the multicenter Gut-Brain Communication in Parkinson’s Disease Consortium (GBPDC), funded by NIDDK/NIH (UO1) from 2024 to…Treatment Patterns and Time Between Therapies Among People with Parkinson’s Disease
Objective: To describe treatment patterns and time to transition between therapies among people treated with Parkinson’s disease (PD) medications, including advanced PD (aPD) or device-aided…Impact of Comorbidities on Clinical Outcomes and Socioeconomic Burden in Parkinson’s Disease: A 10-Year Nationwide Cohort Study
Objective: To evaluate comorbidity prevalence in Parkinson’s disease (PD) and its impact on fracture risk, socioeconomic burden, and overall survival. Background: PD patients frequently present…
- « Previous Page
- 1
- …
- 53
- 54
- 55
- 56
- 57
- …
- 553
- Next Page »